Nuala Moran

Huge increases in R&D spending have translated through to make China’s innovation ecosystem as technologically advanced as in the West, says a new study

Public sector genetic testing laboratories in Europe are ignoring intellectual property rights and deterring investment in the biomarkers that underpin personalised medicine

Despite industry’s endless lip service to driving innovation for the benefit of patients, many diseases go untreated. Now, sick of being passive recipients, patients are taking control and shaping innovation to their real needs

A new transatlantic alliance showcased its ambition to develop diagnostics for 8,000 rare diseases and double the number of registered Orphan drugs for rare conditions by 2020, at the Biotechnology Industry Organization (BIO) meeting in Washington

This week’s European Parliament vote to allow member states to ban cultivation of approved GM crops on environmental grounds undermines science-based decision-making system at an EU level, says Carel du Marchie Sarvaas of EuropaBio

Venture capital is the driving force of much entrepreneurial activity and Europe needs to look to the US role model to understand how it can promote and develop its venture capital sector, says a new report

The UK quoted technology transfer specialist says investors’ appetite for risk has returned. The new money will allow IP Group to up its stake in portfolio companies and form more new ones

Accurate diagnosis and effective treatment of mental illness is a huge unmet medical need. Sabine Bahn was presented with an ACES award at a ceremony at ETH Zurich in February, in recognition of her work in developing blood tests

The Commission is currently wading through more than 2,000 responses to its proposals for the next Framework R&D programme, due to run from 2014 - 2020. With a proposed budget of at least €140 billion there is much to fight for

The contenders for FET flagship status – and €1B funding - may be unprecedented in scale for basic research projects, but they should look to the EIT’s Knowledge and Innovation Communities before expending time and effort on devising new operating models.